Despite not being associated with Crohn's disease susceptibility itself, FOXO3A variants are thought to affect disease outcome via regulation of IL7 and IL2 signalling pathways, whose expression patterns correlate with clinical course of autoimmune diseases [107]. Here, FOXO3 is linked to Crohn disease.